Carbamates of rapamycin

Claim 1

A method of treating restenosis in a mammal in need thereof, which comprises administering to said mammal an antiproliferative effective amount of a compound of the structure ##STR12## wherein R 1 and R 2 are each, independently, hydrogen, --CONR 3 (CR 4 R 5 ) m (CR 6 R 7 ) n (CR 8 R 9 ) p NR 10 R 11 , ##STR13## or CONR 3 R 13 ; R 3 is hydrogen, alkyl of 1-6 carbon atoms, or arylalkyl of 4-10 carbon atoms; R 4 , R 5 , R 8 , and R 9 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, --OH, --CF 3 , or --F; R 6 is hydrogen or --OR 14 ; R 7 is hydrogen or alkyl of 1-6 carbon atoms; R 10 is hydrogen, alkyl of 1-6 carbon atoms, or arylalkyl of 4-10 carbon atoms; R 11 , R 12 , and R 13 are each, independently, --(CR 15 R 16 ) r R 17 ; R 14 is hydrogen, alkyl of 1-6 carbon atoms, tri-(alkyl of 1-6 carbon atoms)silyl, tri-(alkyl of 1-6 carbon atoms)silylethyl, triphenylmethyl, benzyl, alkoxymethyl of 2-7 carbon atoms, tri-(alkyl of 1-6 carbon atoms)silylethoxymethyl, or tetrahydropyranyl; R 15 and R 16 are each, independently, hydrogen or alkyl of 1-6 carbon atoms; ##STR14## or --C≡C--R 21 ; R 18 , R 19 , R 20 , and R 21 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, halogen, or phenyl, wherein the phenyl group may be optionally mono-, di-, or tri-substituted with a group selected from alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, trifluoroalkoxy of 1-6 carbon atoms, cyano, halo, hydroxy, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, dialkylamino of 1-6 carbon atoms per alkyl group, dialkylaminoalkyl of 3-12 carbon atoms, hydroxyalkyl of 1-6 carbon atoms, alkoxyalkyl of 2-12 carbon atoms, alkylthio of 1-6 carbon atoms, --SO 3 H, --PO 3 H, and --CO 2 H; ##STR15## is a 5-7 membered saturated or partially unsaturated heterocyclic radical containing at least 2 ring nitrogens, wherein the heterocyclic ring may optionally contain NR 22 in the heterocyclic ring, and the ring carbons may optionally be substituted by alkyl of 1-6 carbon atoms, arylalkyl of 4-10 carbon atoms, halogen, --CF 3 , --OR 14 , or --CO 2 R 10 ; R 22 is hydrogen, alkyl of 1-6 carbon atoms, or arylalkyl of 4-10 carbon atoms; m=0-6; n=1-6; p=0-6; and r=1-6 with the proviso that R 1 and R 2 are both not hydrogen, or a pharmaceutically acceptable salt thereof.

Claim 2

A method of treating restenosis in a mammal in need thereof, which comprises administering to said mammal an antiproliferative effective amount of a compound of the structure ##STR12## wherein R 1 and R 2 are each, independently, hydrogen, --CONR 3 (CR 4 R 5 ) m (CR 6 R 7 ) n (CR 8 R 9 ) p NR 10 R 11 , ##STR13## or CONR 3 R 13 ; R 3 is hydrogen, alkyl of 1-6 carbon atoms, or arylalkyl of 4-10 carbon atoms; R 4 , R 5 , R 8 , and R 9 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, --OH, --CF 3 , or --F; R 6 is hydrogen or --OR 14 ; R 7 is hydrogen or alkyl of 1-6 carbon atoms; R 10 is hydrogen, alkyl of 1-6 carbon atoms, or arylalkyl of 4-10 carbon atoms; R 11 , R 12 , and R 13 are each, independently, --(CR 15 R 16 ) r R 17 ; R 14 is hydrogen, alkyl of 1-6 carbon atoms, tri-(alkyl of 1-6 carbon atoms)silyl, tri-(alkyl of 1-6 carbon atoms)silylethyl, triphenylmethyl, benzyl, alkoxymethyl of 2-7 carbon atoms, tri-(alkyl of 1-6 carbon atoms)silylethoxymethyl, or tetrahydropyranyl; R 15 and R 16 are each, independently, hydrogen or alkyl of 1-6 carbon atoms; ##STR14## or --C≡C--R 21 ; R 18 , R 19 , R 20 , and R 21 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, halogen, or phenyl, wherein the phenyl group may be optionally mono-, di-, or tri-substituted with a group selected from alkyl of 1-6 carbon atoms, arylalkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, trifluoroalkoxy of 1-6 carbon atoms, cyano, halo, hydroxy, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, amino, dialkylamino of 1-6 carbon atoms per alkyl group, dialkylaminoalkyl of 3-12 carbon atoms, hydroxyalkyl of 1-6 carbon atoms, alkoxyalkyl of 2-12 carbon atoms, alkylthio of 1-6 carbon atoms, --SO 3 H, --PO 3 H, and --CO 2 H; ##STR15## is a 5-7 membered saturated or partially unsaturated heterocyclic radical containing at least 2 ring nitrogens, wherein the heterocyclic ring may optionally contain NR 22 in the heterocyclic ring, and the ring carbons may optionally be substituted by alkyl of 1-6 carbon atoms, arylalkyl of 4-10 carbon atoms, halogen, --CF 3 , --OR 14 , or --CO 2 R 10 ; R 22 is hydrogen, alkyl of 1-6 carbon atoms, or arylalkyl of 4-10 carbon atoms; m=0-6; n=1-6; p=0-6; and r=1-6 with the proviso that R 1 and R 2 are both not hydrogen, or a pharmaceutically acceptable salt thereof.